Other experiments including Western blot were subsequently carried out to provide more evidences that S100A9 may be a potential biomarker in NPC tissue, and the S100A9 level is markedly related to clinical typing of NPC [34]. This evidence concerns the gene S100A9 and nasopharyngeal carcinoma.